FGF19 and Sepsis: In conclusion, serum FGF19 is a risk factor for sepsis combined with GI dysfunction, and the serum FGF19 level at ICU admission can be used as a novel biomarker to predict and evaluate the risk of GI dysfunction in sepsis patients during their ICU stay.